[Muscular blood flow during inhibition of 3', 5'-AMP-phosphodiesterase. Clinical and experimental studies using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
D001157:Arterial Occlusive Diseases / Q000188:drug therapy / Q000628:therapy; D000242:Cyclic AMP; D004106:Dilatation; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009132:Muscles / Q000098:blood supply*; D010726:Phosphodiesterase Inhibitors; D005082:Physical Exertion; D010991:Plethysmography; D012039:Regional Blood Flow / Q000187:drug effects; D014970:Xanthines / Q000494:pharmacology* / Q000627:therapeutic use
D010726:Phosphodiesterase Inhibitors; D014970:Xanthines; D000242:Cyclic AMP
Zum Verhalten der Muskeldurchblutung unter Hemmung der 3',5'-AMP-Phosphodiesterase. Eine klinisch-experimentelle Untersuchung mit 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin.